GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Total Debt per Share

4basebio (LSE:4BB) Total Debt per Share : £0.00 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Total Debt per Share?

£0.00 (As of Jun. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. 4basebio's Total Debt Per Share for the quarter that ended in Jun. 2023 was £0.00.


4basebio Total Debt per Share Historical Data

The historical data trend for 4basebio's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Total Debt per Share Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Total Debt per Share
0.21 0.14 0.14 0.27

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Debt per Share Get a 7-Day Free Trial - 0.14 - 0.27 -

4basebio Total Debt per Share Calculation

4basebio's Total Debt Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

4basebio's Total Debt Per Share for the quarter that ended in Jun. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio Total Debt per Share Related Terms

Thank you for viewing the detailed overview of 4basebio's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (LSE:4BB) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines